Product Information
METHYLPHENIDATE 10 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1580 per EA under NDC 75834032501. Its NADAC has been published 100 times since Nov 6, 2024.
FDA first approved this application on Feb 1, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834032501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208737FDA Approved
2/1/2019
TE Code
AB
On Market Since
4/16/2024
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 10 MG TABLET has been published 100 times since Nov 6, 2024, and over the history we have for it it has declined 9.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1580 per EA |
|---|---|
| All-time high | $0.1897 (Sep 10, 2025) |
| All-time low | $0.1424 (Nov 20, 2024) |
| 52-week high | $0.1890 |
| 52-week low | $0.1580 |
| Median price | $0.1672 |
| Average price | $0.1697 |
| Largest weekly change | -18.0% (Nov 20, 2024) |
| Weeks tracked | 100 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Nivagen Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METHYLPHENIDATE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 10 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1580 per EA (NDC 75834032501), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 10 MG TABLET has declined 9.0%. It has been tracked across 100 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 10 MG TABLET?
Since Nov 6, 2024, the NADAC for METHYLPHENIDATE 10 MG TABLET has ranged from a low of $0.1424 (Nov 20, 2024) to a high of $0.1897 (Sep 10, 2025), with a median of $0.1672 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 10 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE 10 MG TABLET?
METHYLPHENIDATE 10 MG TABLET (NDC 75834032501) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.